Founded Year

2012

Stage

Series D | Alive

Total Raised

$483.64M

Valuation

$0000 

Last Raised

$220M | 3 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-32 points in the past 30 days

About Reify Health

Reify Health specializes in optimizing clinical trial operations within the healthcare sector. The company offers cloud-based software solutions designed to accelerate patient enrollment in clinical trials, aiming to streamline the process of bringing new therapies to patients. Reify Health primarily serves the biopharmaceutical industry, research clinics, and healthcare organizations involved in clinical research. Reify Health was formerly known as ZeroSum Health. It was founded in 2012 and is based in Boston, Massachusetts.

Headquarters Location

33 Arch Street 17th Floor

Boston, Massachusetts, 02110,

United States

931-242-6378

Loading...

ESPs containing Reify Health

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Drug R&D Tech

The decentralized clinical trials platforms market specifically encompasses software and technology solutions designed to facilitate and manage remote clinical trials. These platforms integrate various components such as telemedicine, mobile health applications, and wearable device data collection to enable trial activities without frequent site visits. By streamlining remote participation, these …

Reify Health named as Highflier among 15 other companies, including Medidata, ObvioHealth, and Huma.

Loading...

Expert Collections containing Reify Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Reify Health is included in 3 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,270 items

D

Digital Health

11,305 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

D

Digital Health 50

150 items

The winners of the third annual CB Insights Digital Health 150.

Reify Health Patents

Reify Health has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/6/2010

4/7/2015

Fractals, Dynamical systems, Chemical processes, Systems theory, Robotics

Grant

Application Date

1/6/2010

Grant Date

4/7/2015

Title

Related Topics

Fractals, Dynamical systems, Chemical processes, Systems theory, Robotics

Status

Grant

Latest Reify Health News

Global Virtual Clinical Trials Market Size, Share, And Growth Analysis For 2024-2033

Oct 21, 2024

News Provided By Share This Article Virtual Clinical Trials Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Virtual Clinical Trials Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The virtual clinical trials market size is expected to see rapid growth in the next few years. It will grow to $17.43 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. ” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, October 21, 2024 / EINPresswire.com / -- The virtual clinical trials market has experienced robust growth in recent years, expanding from $10.81 billion in 2023 to $11.83 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased costs of clinical trials, growing need for patient-centric trials, increased demand for remote monitoring, growing adoption of digital technologies in clinical trials, increased need for efficient and cost-effective clinical trial. The virtual clinical trials market is projected to continue its strong growth, reaching $17.43 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing adoption of decentralized clinical trials, increasing use of wearables and other remote monitoring devices, expansion of telehealth services, regulatory support for virtual trial methodologies, cost and time efficiency in trial conduct. Explore Comprehensive Insights Into The Global Virtual Clinical Trials Market With A Detailed Sample Report: Growth Driver Of The Virtual Clinical Trials Market The increasing number of clinical trials is expected to propel the growth of the virtual clinical trials market going forward. Clinical trials are research studies conducted on human participants to evaluate the safety, efficacy, and potential benefits of new medical treatments, interventions, or drugs. The rise in clinical trials has paved the way for the growth and development of virtual clinical trials, offering a more efficient, cost-effective, and patient-friendly approach to conducting clinical research. Explore The Report Store To Make A Direct Purchase Of The Report: Which Market Players Are Driving The Virtual Clinical Trials Market Growth? Key players in the market include ICON plc, Parexel International Pvt. Ltd., IQVIA Holdings Inc., Covance Research Products Inc., Pharmaceutical Research Associates Inc., Medidata Solution Inc., Oracle Corporation, Clario Tech Ltd., Medable Inc., Science 37 Holdings Inc., THREAD Research, Clinical Ink Inc., Veeva Systems Inc., Clinerion Ltd., CRF Health Group Limited, Royal Castor Products Limited, Crio Inc., Deep Lens Inc., Florence Healthcare Inc., goBalto Inc., Medrio Inc., Mint Medical Ltd., Mytrus Inc., OpenClinica LLC, PatientWing, RealTime-CTMS LLC, Reify Health, Sanguine Biosciences Inc., TriNetX Inc., VirTrial LLC What Are The Emerging Trends Shaping The Virtual Clinical Trials Market Size? Major companies operating in the virtual clinical trials market are increasing their focus on partnerships to boost virtual clinical trials. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. How Is The Global Virtual Clinical Trials Market Segmented? 1) By Design: Observational Trials, Interventional Trials, Expanded Access Trials 2) By Phases: Phase I, Phase II, Phase III, Phase IV 3) By Indication: CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications Geographical Insights: North America Leading The Virtual Clinical Trials Market North America was the largest region in the market in 2023. Asia-Pacific is expected to be the fastest-growing region in the report during the forecast period. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The virtual clinical trials refers to remote or decentralized clinical trials or studies that incorporate digital health technologies and enable remote participation outside the traditional brick-and-mortar clinical trial site using tablets, smartphone apps, or wearable sensors. Virtual clinical trials allow significant digital changes in clinical research methodology, resulting in a more patient-centric ecosystem. Virtual Clinical Trials Global Market Report 2024 from The Business Research Company covers the following information: • Market size data for the forecast period: Historical and Future • Macroeconomic factors affecting the market in the short and long run • Analysis of the macro and micro economic factors that have affected the market in the past five years • Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa. • Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. An overview of the global virtual clinical trials market report covering trends, opportunities, strategies, and more The Virtual Clinical Trials Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on virtual clinical trials market size, virtual clinical trials market drivers and trends and virtual clinical trials market growth across geographies. This report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential. Browse Through More Similar Reports By The Business Research Company: Virtual Reality In Healthcare Global Market Report 2024

Reify Health Frequently Asked Questions (FAQ)

  • When was Reify Health founded?

    Reify Health was founded in 2012.

  • Where is Reify Health's headquarters?

    Reify Health's headquarters is located at 33 Arch Street, Boston.

  • What is Reify Health's latest funding round?

    Reify Health's latest funding round is Series D.

  • How much did Reify Health raise?

    Reify Health raised a total of $483.64M.

  • Who are the investors of Reify Health?

    Investors of Reify Health include Battery Ventures, Adams Street Partners, Coatue, Dragoneer Investment Group, ICONIQ Growth and 8 more.

  • Who are Reify Health's competitors?

    Competitors of Reify Health include Castor, ObvioHealth, Science 37, Pentavere Research Group, Curebase and 7 more.

Loading...

Compare Reify Health to Competitors

Medable Logo
Medable

Medable specializes in providing digital clinical trial software solutions within the healthcare and pharmaceutical sectors. The company offers a comprehensive platform that facilitates the management of clinical trials, including tools for remote data collection, electronic consent (eConsent), patient-reported outcomes (ePRO), and clinical outcome assessments (eCOA), all designed to streamline the trial process and enhance data quality. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

Curebase Logo
Curebase

Curebase provides a range of software tools designed for clinical trial recruitment, consent, and data collection processes. Curebase primarily serves the clinical research industry, including CROs, research sites, and study participants. The company was founded in 2017 and is based in San Francisco, California.

THREAD Logo
THREAD

THREAD is a company focused on clinical research and electronic clinical outcome assessments (eCOA) within the life sciences sector. It offers a proprietary decentralized research platform and a suite of supporting services designed to enable remote data capture from participants and sites during clinical studies. It was founded in 2005 and is based in Tustin, California.

Formation Bio Logo
Formation Bio

Formation Bio is an artificial intelligence (AI) native pharmaceutical company that focuses on drug development. It specializes in acquiring and developing clinical-stage drugs more efficiently by leveraging a proprietary technology platform that incorporates artificial intelligence. Formation Bio primarily serves the pharmaceutical industry by expediting the drug development process for various therapeutic areas. It was formerly known as TrialSpark. It was founded in 2013 and is based in New York, New York.

ObvioHealth Logo
ObvioHealth

ObvioHealth provides digital health solutions within the clinical trial industry. The company has a platform and mobile application allows for remote monitoring and participation in clinical trials, focusing on data collection and participant engagement. ObvioHealth's services are relevant to the healthcare sector, especially in trial management. It was founded in 2017 and is based in New York, New York.

BloqCube Logo
BloqCube

BloqCube is a software company specializing in decentralized clinical trial management and financial systems. The company offers an integrated Clinical Trial Management & Financial System (CTMFS) platform designed to accelerate Decentralized Clinical Trials (DCT) by providing a secure, transparent, and efficient way to manage trials and handle financial transactions. BloqCube primarily serves the healthcare and pharmaceutical sectors by streamlining clinical trial processes and financial management. It was founded in 2017 and is based in Piscataway, New Jersey.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.